Saydon Pharmaceutical Industries Private Limited delivers trusted, affordable and science-backed formulations — manufactured in world-class facilities and trusted by healthcare professionals across 18 countries.
Founded with a singular purpose — to make world-class medicine accessible — Saydon Pharmaceutical Industries Private Limited has grown into a multi-facility organisation serving hospitals, institutions and retail networks across domestic and international markets.
Our state-of-the-art plants operate under stringent WHO-GMP norms, supported by a dedicated R&D centre, analytical laboratories and a validated supply chain that safeguards product integrity from batch to bedside.
Over 480 formulations spanning chronic care, acute therapy and wellness — developed to meet the evolving needs of clinicians and patients.
Antihypertensives, statins, antiplatelets and cardiac care combinations engineered for consistent bioavailability.
Oral hypoglycaemics, insulin adjuvants and diabetic care supplements supporting long-term glycaemic control.
Broad and narrow spectrum antibiotics, antifungals and antivirals manufactured under strict sterility controls.
Proton pump inhibitors, prokinetics, hepatoprotectives and probiotic blends for digestive health management.
Anticonvulsants, antidepressants and neurotropic formulations developed with precision dosing accuracy.
Vitamins, minerals, antioxidants and wellness supplements in innovative, patient-friendly dosage forms.
Ceftriaxone 500 mg sterile powder for injection, indicated for severe bacterial infections.
Metformin Hydrochloride 500 mg sustained-release tablets for type 2 diabetes management.
Pantoprazole 40 mg enteric-coated tablets for acid-related gastrointestinal disorders.
Cholecalciferol 60,000 IU soft gelatin capsules supporting bone and immune health.
Every batch that leaves a Saydon facility is the result of validated processes, rigorous in-process checks and independent analytical verification. Our Quality Management System is designed to exceed the expectations of global regulators.
Every API and excipient is quarantined and tested against pharmacopoeial monographs before release to production.
Real-time parameter monitoring on automated lines ensures uniformity of weight, hardness, dissolution and fill volume.
HPLC, GC, UV and dissolution laboratories validate identity, potency, purity and performance of finished products.
Ongoing stability programmes and a robust pharmacovigilance system safeguard product performance in real-world use.
The new line expands tablet packaging capacity by 40% while improving serialisation readiness for export markets.
Read ArticleOur flagship formulation facility has been recertified following a comprehensive good manufacturing practice inspection.
Read ArticleAn in-house matrix technology designed to reduce dosing frequency for chronic therapy patients moves to Phase II validation.
Read ArticleShare your requirement and our team will respond within one business day with product availability, documentation and pricing.
For product enquiries, distribution partnerships, career opportunities or media requests.
Saydon Pharmaceutical, Plot No.77-A, Hayatabad Industrial Estate,
Peshawar, Khyber Pukhtunkhwa, Pakistan
Monday – Saturday: 8:00 AM – 4:00 PM PST
Sunday: Closed